Indego Exoskeleton After SCI

NCT ID: NCT02793635

Last Updated: 2018-08-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

9 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-06-30

Study Completion Date

2018-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to assess the use of Indego as a gait training tool for subjects with complete or incomplete paraplegia as a result of spinal cord injury (SCI) who have preserved lower extremity function. It is hypothesized that subjects with complete or incomplete paraplegia who have preserved their lower extremity function will experience functional improvements after gait training with the Indego exoskeleton.

Subjects will complete a total of fifteen (15) sessions which include a combination of the following; Physical Therapy Evaluation, Indego Training, Mid-Way Assessment, and Post-Assessment.

The aim of this study is to measure the impact of gait training with the Indego device on body structure, function, and participation. Additionally it will assess the perceptions of physical therapists and subjects with SCI on the effectiveness of gait training with the Indego exoskeleton in subjects with preserved limited function.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Spinal Cord Injury

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

SCI Patients

* 10 subjects with complete or incomplete SCI (\> 1 year post-injury) with preserved LE function will be recruited.
* No control group

Group Type EXPERIMENTAL

Indego Powered Exoskeleton

Intervention Type DEVICE

Subjects who have Spinal Cord Injury will wear the Indego device which will include being trained and evaluated for fifteen (15) sessions.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Indego Powered Exoskeleton

Subjects who have Spinal Cord Injury will wear the Indego device which will include being trained and evaluated for fifteen (15) sessions.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Vanderbilt exoskeleton

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years or older
* Height 5'1" to 6'3" (Acceptable height may vary by a few inches depending on femur length)
* Weight 250 lbs or less
* Present with paraplegia resulting from a complete or incomplete (AIS A, B, C, or D) Spinal Cord Injury (\>1 year post-injury), with preserved LE function
* Uses wheelchair as primary means of mobility in the community
* Able to ambulate 14 meters with assist of 2 people and no orthostasis. Subjects may use any combination of stability aids and/or bracing.
* Medical clearance for weight bearing and locomotor training

* Bone density exams will be at the discretion of each sites' Principle Investigator
* Passive range of motion (PROM) at shoulders, trunk, hips, knees and ankles within functional limits for safe gait and use of appropriate assistive device/stability aid
* Skin intact where interfaces with the Indego device
* Modified Ashworth Scale 3 or less in bilateral LEs
* Blood pressure and heart rate within Locomotor Training Guidelines

* At rest: Systolic 150 or less Diastolic 90 or less and Heart rate 105 or less
* Exercise: Systolic 180 or less Diastolic 105 or less and Heart Rate 145 or less

* Currently participating in physical therapy for gait training
* Joint contractures of the shoulders, trunk, hips knees or ankles deemed unsafe for locomotor training by PT and or MD
* Edema that would put skin at risk for breakdown
* Modified Ashworth Spasticity of 4
* Inability to achieve adequate fit of the Indego device
* Pregnancy
* Colostomy bag
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Parker Hannifin Corporation

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

St. Charles Hospital

Port Jefferson, New York, United States

Site Status

TIRR Memorial Hermann

Houston, Texas, United States

Site Status

Sheltering Arms

Mechanicsville, Virginia, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

15-01399

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Exoskeleton and Spinal Cord Injury
NCT03410550 COMPLETED PHASE2